These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29666441)

  • 1. Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours.
    Dufresne A; Brahmi M; Karanian M; Blay JY
    Nat Rev Clin Oncol; 2018 Jul; 15(7):443-458. PubMed ID: 29666441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience.
    Cote GM; He J; Choy E
    Oncologist; 2018 Feb; 23(2):234-242. PubMed ID: 28860410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There Value in Molecular Profiling of Soft-Tissue Sarcoma?
    Italiano A
    Curr Treat Options Oncol; 2018 Dec; 19(12):78. PubMed ID: 30523434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of sarcoma development.
    Helman LJ; Meltzer P
    Nat Rev Cancer; 2003 Sep; 3(9):685-94. PubMed ID: 12951587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Targeted treatment of rare connective tissue tumors and sarcomas].
    Cassier P; Pissaloux D; Alberti L; Ray-Coquard I; Blay JY
    Bull Cancer; 2010 Jun; 97(6):693-700. PubMed ID: 20497911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of sarcomagenesis.
    Matushansky I; Maki RG
    Hematol Oncol Clin North Am; 2005 Jun; 19(3):427-49, v. PubMed ID: 15939190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
    Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
    Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing for the management of sarcomas with no known driver mutations.
    Vyse S; Thway K; Huang PH; Jones RL
    Curr Opin Oncol; 2021 Jul; 33(4):315-322. PubMed ID: 33927108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapies for sarcomas: new roles for the pathologist.
    Al-Zaid T; Somaiah N; Lazar AJ
    Histopathology; 2014 Jan; 64(1):119-33. PubMed ID: 24117526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives.
    Brenca M; Maestro R
    Expert Rev Anticancer Ther; 2015; 15(12):1473-88. PubMed ID: 26536249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
    Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
    Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in sarcoma gene mutations and therapeutic targets.
    Gao P; Seebacher NA; Hornicek F; Guo Z; Duan Z
    Cancer Treat Rev; 2018 Jan; 62():98-109. PubMed ID: 29190505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular karyotyping in sarcoma diagnostics and research.
    Vauhkonen H; Savola S; Kaur S; Larramendy ML; Knuutila S
    Adv Exp Med Biol; 2006; 587():53-63. PubMed ID: 17163155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update in the management of pediatric sarcoma.
    Sandler G; Yokoi A; Hayes-Jordan A
    Curr Opin Pediatr; 2019 Jun; 31(3):368-377. PubMed ID: 31090579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience.
    Tirrò E; Martorana F; Micale G; Inzerilli N; Carciotto R; Romano C; Longhitano C; Motta G; Lanzafame K; Stella S; Massimino M; Vitale SR; Salvatorelli L; Magro G; Manzella L; Vigneri P
    Pathol Res Pract; 2022 Apr; 232():153820. PubMed ID: 35240549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
    Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
    Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology of sarcoma and therapeutic choices].
    Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
    Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
    Drilon A; Wang L; Arcila ME; Balasubramanian S; Greenbowe JR; Ross JS; Stephens P; Lipson D; Miller VA; Kris MG; Ladanyi M; Rizvi NA
    Clin Cancer Res; 2015 Aug; 21(16):3631-9. PubMed ID: 25567908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.